OtherBasic Science Investigations
Validation of FLT Uptake as a Measure of Thymidine Kinase-1 Activity in A549 Carcinoma Cells
Janet S. Rasey, John R. Grierson, Linda W. Wiens, Pamella D. Kolb and Jeffrey L. Schwartz
Journal of Nuclear Medicine September 2002, 43 (9) 1210-1217;
Janet S. Rasey
John R. Grierson
Linda W. Wiens
Pamella D. Kolb

Article Information
vol. 43 no. 9 1210-1217
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online September 1, 2002.
Copyright & Usage
THE JOURNAL OF NUCLEAR MEDICINE
Author Information
Statistics from Altmetric.com
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
Article usage
In this issue
Validation of FLT Uptake as a Measure of Thymidine Kinase-1 Activity in A549 Carcinoma Cells
Janet S. Rasey, John R. Grierson, Linda W. Wiens, Pamella D. Kolb, Jeffrey L. Schwartz
Journal of Nuclear Medicine Sep 2002, 43 (9) 1210-1217;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Metabolic Phenotypes, Dependencies, and Adaptation in Lung Cancer
- Streptococcus pneumoniae Binds to Host Lactate Dehydrogenase via PspA and PspC To Enhance Virulence
- 17-Allylamino-17-demethoxygeldanamycin-induced Changes in [18F]Fluorothymidine Uptake
- Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 Patients
- Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy
- Mapping Radiation Injury and Recovery in Bone Marrow Using 18F-FLT PET/CT and USPIO MRI in a Rat Model
- The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis
- Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging
- 18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome
- PET Imaging During Radiotherapy of Head and Neck Cancer
- 3'-Deoxy-3'-18F-Fluorothymidine PET Predicts Response to V600EBRAF-Targeted Therapy in Preclinical Models of Colorectal Cancer
- Correlation of 18F-FLT Uptake with Tumor Grade and Ki-67 Immunohistochemistry in Patients with Newly Diagnosed and Recurrent Gliomas
- Usefulness of 3'-Deoxy-3'-18F-Fluorothymidine PET for Predicting Early Response to Chemoradiotherapy in Head and Neck Cancer
- [18F]FLT-PET Imaging Does Not Always "Light Up" Proliferating Tumor Cells
- PET Imaging of Tumor Growth: Not as Easy as It Looks
- 4'-[Methyl-11C]-Thiothymidine PET/CT for Proliferation Imaging in Non-Small Cell Lung Cancer
- Pharmacodynamic Study Using FLT PET/CT in Patients with Renal Cell Cancer and Other Solid Malignancies Treated with Sunitinib Malate
- Multimodality Assessment of Brain Tumors and Tumor Recurrence
- Tumor 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) Uptake by PET Correlates with Thymidine Kinase 1 Expression: Static and Kinetic Analysis of 18F-FLT PET Studies in Lung Tumors
- Quantitative Analysis of Thymidine Kinase 1 and 5'(3')-Deoxyribonucleotidase mRNA Expression: The Role of Fluorothymidine Uptake
- The future of imaging: developing the tools for monitoring response to therapy in oncology: the 2009 Sir James MacKenzie Davidson Memorial lecture
- Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells
- 18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors
- PET/CT with 18F-FLT: Does It Improve the Therapeutic Management of Metastatic Germ Cell Tumors?
- Noninvasive Imaging of Endogenous Neural Stem Cell Mobilization In Vivo Using Positron Emission Tomography
- Histopathologic Validation of 3'-Deoxy-3'-18F-Fluorothymidine PET in Squamous Cell Carcinoma of the Oral Cavity
- Kinetic Analysis of 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy
- PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
- Cytotoxicity of {sigma}-Receptor Ligands Is Associated with Major Changes of Cellular Metabolism and Complete Occupancy of the {sigma}-2 Subpopulation
- First Demonstration of Leukemia Imaging with the Proliferation Marker 18F-Fluorodeoxythymidine
- The Role of Human Nucleoside Transporters in Uptake of 3'-Deoxy-3'-fluorothymidine
- Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901
- Glioma Proliferation as Assessed by 3'-Fluoro-3'-Deoxy-L-Thymidine Positron Emission Tomography in Patients with Newly Diagnosed High-Grade Glioma
- 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Is a Sensitive Method for Imaging the Response of BRAF-Dependent Tumors to MEK Inhibition
- Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pilot Study
- Clinical Applications of PET in Brain Tumors
- Early Response Assessment Using 3'-Deoxy-3'-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma
- Multimodality Molecular Imaging of Glioblastoma Growth Inhibition with Vasculature-Targeting Fusion Toxin VEGF121/rGel
- Molecular Imaging of Proliferation in Malignant Lymphoma.
- Early Response of {sigma}-Receptor Ligands and Metabolic PET Tracers to 3 Forms of Chemotherapy: An In Vitro Study in Glioma Cells
- Early Detection of Chemoradioresponse in Esophageal Carcinoma by 3'-Deoxy-3'-3H-Fluorothymidine Using Preclinical Tumor Models
- In vivo Biological Activity of the Histone Deacetylase Inhibitor LAQ824 Is detectable with 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography
- 18F-Fluoro-L-Thymidine and 11C-Methylmethionine as Markers of Increased Transport and Proliferation in Brain Tumors
- Quantification of Cellular Proliferation in Tumor and Normal Tissues of Patients with Breast Cancer by [18F]Fluorothymidine-Positron Emission Tomography Imaging: Evaluation of Analytical Methods
- Reproducibility of 3'-Deoxy-3'-18F-Fluorothymidine MicroPET Studies in Tumor Xenografts in Mice
- Imaging Proliferation in Brain Tumors with 18F-FLT PET: Comparison with 18F-FDG
- Early Detection of Tumor Response to Chemotherapy by 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography: The Effect of Cisplatin on a Fibrosarcoma Tumor Model In vivo
- Kinetic Analysis of 3'-Deoxy-3'-Fluorothymidine PET Studies: Validation Studies in Patients with Lung Cancer
- Kinetic Modeling of 3'-Deoxy-3'-Fluorothymidine in Somatic Tumors: Mathematical Studies
- Monitoring Antiproliferative Responses to Kinase Inhibitor Therapy in Mice with 3'-Deoxy-3'-18F-Fluorothymidine PET
- Selectivity of 18F-FLT and 18F-FDG for Differentiating Tumor from Inflammation in a Rodent Model
- Monitoring of Therapy in Androgen-Dependent Prostate Tumor Model by Measuring Tumor Proliferation
- Oncological molecular imaging: nuclear medicine techniques
- Reply
- Monitoring Tumor Cell Proliferation by Targeting DNA Synthetic Processes with Thymidine and Thymidine Analogs
- Molecular Targeting with Radionuclides: State of the Science
- In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography
- PET Imaging with 18F-FLT and Thymidine Analogs: Promise and Pitfalls
- Imaging Proliferation in Lung Tumors with PET: 18F-FLT Versus 18F-FDG
- 18F-Fluorothymidine Radiation Dosimetry in Human PET Imaging Studies
- 3'-Deoxy-3'-[18F]Fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative Therapy in Vivo with Positron Emission Tomography
- 3'-[18F]Fluoro-3'-Deoxythymidine ([18F]-FLT) as Positron Emission Tomography Tracer for Imaging Proliferation in a Murine B-Cell Lymphoma Model and in the Human Disease